Arpita Aditya
Research Subjects
Arpita Aditya has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah-Al-Kamran Khan
Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
1 shared publication - Ashrafun Nessa
Affiliation Department of Gynaecological Oncology, Bangladesh Medical University (BMU), Dhaka, Bangladesh
1 shared publication Bristy Sabikunnahar
Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh
1 shared publication- C Highsmith
Verb Biotics LLC, Boston, MA 02210, USA
1 shared publication - Camille J. Delebecque
Verb Biotics LLC, Boston, MA, USA
1 shared publication - Chowdhury Rafiqul Ahsan
Department of Microbiology, University of Dhaka, Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- p. 1-9
Mechanistic characterisation of a novel oat-based postbiotic: microbiome modulation, barrier protection, and wound healing.
Postbiotics, the inactivated microorganisms and their products derived from fermentation, represent an evolution in the rapidly growing biotics industry and extend health benefits without the need for bacterial viability. In this study, we explored the potential of a novel oat-based postbiotic to provide health benefits by modulating the host immune system and gut microbiome. Two Lactobacillus species, Lactiplantibacillus plantarum 276 and Lacticaseibacillus rhamnosus GG, were used together to ferment 15% oat flour for 24 h at 37 °C followed by pasteurisation and freeze-drying to produce the oat-based postbiotic (OP). OP (1 mg/ml) was used to pretreat a mammalian intestinal epithelial cell line (Caco-2) for 1 h before stimulation with TNF-α and IL-1β (10 ng/ml each). The immuno-modulatory and barrier-supporting effect of OP were evaluated by measuring transepithelial electrical resistance (TEER), wound healing, and expression of cytokines genes (IL-6 and CXCL-8) as well as in a nematode (Caenorhabditis elegans) model. OP protected intestinal barrier integrity as measured by TEER in Caco-2 cells and in the C. elegans model. IL-6 and CXCL-8 expressions in OP pretreated cells were upregulated and OP promoted significant wound closure within 24 h. OP also markedly modulated the human gut microbiome as demonstrated by a 6.48-fold increase in native Bifidobacterium spp. in the in vitro human faecal model. Findings of this study suggest that OP is a novel, safe, stable, and effective intervention for foundational gut health and overall wellness.
- 7 July 2026
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- p. 1-9
Open AccessMechanistic characterisation of a novel oat-based postbiotic: microbiome modulation, barrier protection, and wound healing.
Postbiotics, the inactivated microorganisms and their products derived from fermentation, represent an evolution in the rapidly growing biotics industry and extend health benefits without the need for bacterial viability. In this study, we explored the potential of a novel oat-based postbiotic to provide health benefits by modulating the host immune system and gut microbiome. Two Lactobacillus species, Lactiplantibacillus plantarum 276 and Lacticaseibacillus rhamnosus GG, were used together to ferment 15% oat flour for 24 h at 37 °C followed by pasteurisation and freeze-drying to produce the oat-based postbiotic (OP). OP (1 mg/ml) was used to pretreat a mammalian intestinal epithelial cell line (Caco-2) for 1 h before stimulation with TNF-α and IL-1β (10 ng/ml each). The immuno-modulatory and barrier-supporting effect of OP were evaluated by measuring transepithelial electrical resistance (TEER), wound healing, and expression of cytokines genes (IL-6 and CXCL-8) as well as in a nematode (Caenorhabditis elegans) model. OP protected intestinal barrier integrity as measured by TEER in Caco-2 cells and in the C. elegans model. IL-6 and CXCL-8 expressions in OP pretreated cells were upregulated and OP promoted significant wound closure within 24 h. OP also markedly modulated the human gut microbiome as demonstrated by a 6.48-fold increase in native Bifidobacterium spp. in the in vitro human faecal model. Findings of this study suggest that OP is a novel, safe, stable, and effective intervention for foundational gut health and overall wellness.
- Open Access
- 21 October 2021
- Published by Elsevier in IJID Regions
- Vol. 1, 130-134
Genotypic distribution and prevalence of human papillomavirus infection in an apparently healthy female population in Bangladesh
- 21 October 2021
- Published by Elsevier in IJID Regions
- Vol. 1, 130-134
Open AccessGenotypic distribution and prevalence of human papillomavirus infection in an apparently healthy female population in Bangladesh